Evolution of Early-Phase Anticancer Drug Investigations in China

This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021.

Detalles Bibliográficos
Autores principales: Wang, Shuhang, Yu, Yue, Jiang, Yale, Zhang, Huishan, Ma, Peiwen, Liu, Gang, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459900/
https://www.ncbi.nlm.nih.gov/pubmed/36074496
http://dx.doi.org/10.1001/jamaoncol.2022.3856
_version_ 1784786619484602368
author Wang, Shuhang
Yu, Yue
Jiang, Yale
Zhang, Huishan
Ma, Peiwen
Liu, Gang
Li, Ning
author_facet Wang, Shuhang
Yu, Yue
Jiang, Yale
Zhang, Huishan
Ma, Peiwen
Liu, Gang
Li, Ning
author_sort Wang, Shuhang
collection PubMed
description This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021.
format Online
Article
Text
id pubmed-9459900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-94599002022-09-24 Evolution of Early-Phase Anticancer Drug Investigations in China Wang, Shuhang Yu, Yue Jiang, Yale Zhang, Huishan Ma, Peiwen Liu, Gang Li, Ning JAMA Oncol Research Letter This study examines phase 1 anticancer drug clinical trials performed in China from 2017 to 2021. American Medical Association 2022-09-08 2022-11 /pmc/articles/PMC9459900/ /pubmed/36074496 http://dx.doi.org/10.1001/jamaoncol.2022.3856 Text en Copyright 2022 Wang S et al. JAMA Oncology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Wang, Shuhang
Yu, Yue
Jiang, Yale
Zhang, Huishan
Ma, Peiwen
Liu, Gang
Li, Ning
Evolution of Early-Phase Anticancer Drug Investigations in China
title Evolution of Early-Phase Anticancer Drug Investigations in China
title_full Evolution of Early-Phase Anticancer Drug Investigations in China
title_fullStr Evolution of Early-Phase Anticancer Drug Investigations in China
title_full_unstemmed Evolution of Early-Phase Anticancer Drug Investigations in China
title_short Evolution of Early-Phase Anticancer Drug Investigations in China
title_sort evolution of early-phase anticancer drug investigations in china
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459900/
https://www.ncbi.nlm.nih.gov/pubmed/36074496
http://dx.doi.org/10.1001/jamaoncol.2022.3856
work_keys_str_mv AT wangshuhang evolutionofearlyphaseanticancerdruginvestigationsinchina
AT yuyue evolutionofearlyphaseanticancerdruginvestigationsinchina
AT jiangyale evolutionofearlyphaseanticancerdruginvestigationsinchina
AT zhanghuishan evolutionofearlyphaseanticancerdruginvestigationsinchina
AT mapeiwen evolutionofearlyphaseanticancerdruginvestigationsinchina
AT liugang evolutionofearlyphaseanticancerdruginvestigationsinchina
AT lining evolutionofearlyphaseanticancerdruginvestigationsinchina

Ejemplares similares